On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds

Article metrics

Abstract

Backbone N-methylation is common among peptide natural products and has a substantial impact on both the physical properties and the conformational states of cyclic peptides. However, the specific impact of N-methylation on passive membrane diffusion in cyclic peptides has not been investigated systematically. Here we report a method for the selective, on-resin N-methylation of cyclic peptides to generate compounds with drug-like membrane permeability and oral bioavailability. The selectivity and degree of N-methylation of the cyclic peptide was dependent on backbone stereochemistry, suggesting that conformation dictates the regiochemistry of the N-methylation reaction. The permeabilities of the N-methyl variants were corroborated by computational studies on a 1,024-member virtual library of N-methyl cyclic peptides. One of the most permeable compounds, a cyclic hexapeptide (molecular mass = 755 Da) with three N-methyl groups, showed an oral bioavailability of 28% in rat.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Schematic representation of the conformational hypothesis and on-resin N-methylation strategy.
Figure 2: Diastereomer library screened for N-methylation selectivity and consensus sequences for most selective scaffolds.
Figure 3: Most selective scaffolds, their N-methylation products and H-D exchange studies.
Figure 4: Results of PAMPA permeability studies and structure of compound 7.
Figure 5: Analysis of computational studies on a virtual library of N-methyl cyclic peptides.

References

  1. 1

    Driggers, E.M., Hale, S.P., Lee, J. & Terrett, N.K. The exploration of macrocycles for drug discovery—an underexploited structural class. Nat. Rev. Drug Discov. 7, 608–624 (2008).

  2. 2

    Bauer, R.A., Wurst, J.M. & Tan, D.S. Expanding the range of 'druggable' targets with natural product-based libraries: an academic perspective. Curr. Opin. Chem. Biol. 14, 308–314 (2010).

  3. 3

    Kim, Y.K. et al. Relationship of stereochemical and skeletal diversity of small molecules to cellular measurement space. J. Am. Chem. Soc. 126, 14740–14745 (2004).

  4. 4

    Biron, E. et al. Improving oral bioavailability of peptides by multiple N-methylation: somatostatin analogues. Angew. Chem. Int. Edn Engl. 47, 2595–2599 (2008).

  5. 5

    Doedens, L. et al. Multiple N-methylation of MT-II backbone amide bonds leads to melanocortin receptor subtype hMC1R selectivity: pharmacological and conformational studies. J. Am. Chem. Soc. 132, 8115–8128 (2010).

  6. 6

    Chatterjee, J., Gilon, C., Hoffman, A. & Kessler, H. N-methylation of peptides: a new perspective in medicinal chemistry. Acc. Chem. Res. 41, 1331–1342 (2008).

  7. 7

    Ovadia, O. et al. The effect of multiple N-methylation on intestinal permeability of cyclic hexapeptides. Mol. Pharm. 8, 479–487 (2011).

  8. 8

    Dechantsreiter, M.A. et al. N-Methylated cyclic RGD peptides as highly active and selective aVb3 integrin antagonists. J. Med. Chem. 42, 3033–3040 (1999).

  9. 9

    Loosli, H.R. et al. Peptide conformations. Part 31. The conformation of cyclosporin A in the crystal and in solution. Helv. Chim. Acta 68, 682–704 (1985).

  10. 10

    In, Y., Ishida, T. & Takesako, K. Unique molecular conformation of aureobasidin A, a highly amide N-methylated cyclic depsipeptide with potent antifungal activity: X-ray crystal structure and molecular modeling studies. J. Pept. Res. 53, 492–500 (1999).

  11. 11

    Steiner, J.R. & Barnes, C.L. Crystal and molecular structure of Destruxin-B. Int. J. Pept. Protein Res. 31, 212–219 (1988).

  12. 12

    Rezai, T., Yu, B., Millhauser, G.L., Jacobson, M.P. & Lokey, R.S. Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide Diastereomers. J. Am. Chem. Soc. 128, 2510–2511 (2006).

  13. 13

    Rezai, T. et al. Conformational flexibility, internal hydrogen bonding, and passive membrane permeability: successful in silico prediction of the relative permeabilities of cyclic peptides. J. Am. Chem. Soc. 128, 14073–14080 (2006).

  14. 14

    Boguslavsky, V., Hruby, V.J., Brien, D.F.O., Misicka, A. & Lipkowski, A.W. Effect of peptide conformation on membrane permeability. J. Pept. Res. 61, 287–297 (2003).

  15. 15

    Gudmundsson, O.S. et al. The effect of conformation on the membrane permeation of coumarinic acid- and phenylpropionic acid-based cyclic prodrugs of opioid peptides. J. Pept. Res. 53, 383–392 (1999).

  16. 16

    Knipp, G.T., Vander Velde, D.G., Siahaan, T.J. & Borchardt, R.T. The effect of beta-turn structure on the passive diffusion of peptides across Caco-2 cell monolayers. Pharm. Res. 14, 1332–1340 (1997).

  17. 17

    Ashwood, V.A. et al. Utilization of an intramolecular hydrogen bond to increase the CNS penetration of an NK1 receptor antagonist. J. Med. Chem. 44, 2276–2285 (2001).

  18. 18

    Davies, J.S. The cyclization of peptides and depsipeptides. J. Pept. Sci. 9, 471–501 (2003).

  19. 19

    Houghten, R.A. et al. Libraries from libraries: generation and comparison of screening profiles. Mol. Divers. 2, 41–45 (1996).

  20. 20

    Dorner, B., Ostresh, J., Blondelle, S., Dooley, C. & Houghten, R. Peptidomimetic synthetic combinatorial libraries in Peptidomimetic Synthetic Combinatorial Libraries, Vol. 1. (ed. Abell, A.) 109–126 (JAI Press, 1997).

  21. 21

    Gurrath, M., Muller, G., Kessler, H., Aumailley, M. & Timpl, R. Conformation/activity studies of rationally designed potent anti-adhesive RGD peptides. Eur. J. Biochem. 210, 911–921 (1992).

  22. 22

    Kansy, M., Senner, F. & Gubernator, K. Physicochemical high throughput screening: Parallel artificial membrane permeation assay in the description of passive absorption processes. J. Med. Chem. 41, 1007–1010 (1998).

  23. 23

    Fujikawa, M., Ano, R., Nakao, K., Shimizu, R. & Akamatsu, M. Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability. Bioorg. Med. Chem. 13, 4721–4732 (2005).

  24. 24

    Bermejo, M. et al. PAMPA–a drug absorption in vitro model 7. Comparing rat in situ, Caco-2, and PAMPA permeability of fluoroquinolones. Eur. J. Pharm. Sci. 21, 429–441 (2004).

  25. 25

    Jacobson, M.P. et al. A hierarchical approach to all-atom protein loop prediction. Proteins 55, 351–367 (2004).

  26. 26

    Miller, S.C. & Scanlan, T.S. Site-selective N-methylation of peptides on solid support. J. Am. Chem. Soc. 119, 2301–2302 (1997).

  27. 27

    Hwang, K.K., Martin, N.E., Jiang, L. & Zhu, C. Permeation prediction of M100240 using the parallel artificial membrane permeability assay. J. Pharm. Pharm. Sci. 6, 315–320 (2003).

  28. 28

    Fukushima, K. et al. Effect of serum lipids on the pharmacokinetics of atazanavir in hyperlipidemic rats. Biomed. Pharmacother. 63, 635–642 (2009).

  29. 29

    Jin, M. et al. Long-term levothyroxine treatment decreases the oral bioavailability of cyclosporin A by inducing P-glycoprotein in small intestine. Drug Metab. Pharmacokinet. 20, 324–330 (2005).

  30. 30

    Fukushima, K. et al. Long-term pharmacokinetic efficacy and safety of low-dose ritonavir as a booster and atazanavir pharmaceutical formulation based on solid dispersion system in rats. Biol. Pharm. Bull. 31, 1209–1214 (2008).

  31. 31

    Steffel, L.R., Cashman, T.J., Reutershan, M.H. & Linton, B.R. Deuterium exchange as an indicator of hydrogen bond donors and acceptors. J. Am. Chem. Soc. 129, 12956–12957 (2007).

  32. 32

    Veber, D.F. et al. A potent cyclic hexapeptide analogue of somatostatin. Nature 292, 55–58 (1981).

Download references

Acknowledgements

The synthesis and analytical results were supported by US National Institutes of Health grant GM084530-06 (R.S.L.). The computational results were supported by US National Institutes of Health grant R01-GM086602 to M.P.J. M.P.J. is a consultant to Schrodinger LLC. Cell-based assays and in vivo pharmacokinetics were provided by Pfizer.

Author information

T.R.W. synthesized the diastereomer library, developed on-resin N-methylation chemistry, performed PAMPA studies, and synthesized compounds 16 and the leucine-to-serine analogs. C.M.R. performed NMR experiments and analyzed data to determine patterns of N-methylation. A.C.R. synthesized and performed H-D exchange studies on compound 7. T.R. contributed to the development of the on-resin N-methylation chemistry. C.M.M. coordinated experiments and contributed to manuscript preparation. V.M.G. assisted in analysis of 2D NMR data for 3 and 4. R.A.T. contributed to synthesis method development and analytical procedures for PAMPA and compound characterization. R.G.L. provided guidance in developing NMR methods to determine pattern of N-methylation for 3, 4 and 7. S.S.F.L. performed computational studies, generated virtual libraries and predicted permeabilities of virtual compounds. A.S.K., J.N.B., Y.Z., S.L., D.A.P. and A.M.M. designed pharmacokinetic studies and interpreted results of in vitro and in vivo absorption, distribution, metabolism and excretion and pharmacokinetic data. M.P.J. developed computational methodology for predicting permeability, designed experiments and discussed results. R.S.L. conceived the on-resin N-methylation approach and designed experiments. A.S.K., J.N.B., Y.Z., S.L., D.A.P., A.M.M., M.P.J. and R.S.L. discussed results and wrote the paper.

Correspondence to Matthew P Jacobson or R Scott Lokey.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Methods and Supplementary Results (PDF 10837 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

White, T., Renzelman, C., Rand, A. et al. On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds. Nat Chem Biol 7, 810–817 (2011) doi:10.1038/nchembio.664

Download citation

Further reading